Doran v. Takeda Pharmaceuticals U.S.A., Inc. et al
| Carol L. Doran |
| Astrazeneca LP, Takeda Pharmaceutical Company Limited, Takeda pharmaceuticals U.S.A., Inc., AstraZeneca Pharmaceuticals LP, Takeda Pharmaceuticals America, Inc., MERCK & CO., INC. D/B/A MERCK, SHARP & DOHME CORPORATION, Pfizer, Inc., Takeda Development Center Americas, Inc., F/K/A Takeda Global Research & Development Center, Inc., Merck & Co., Inc. and Takeda Development Center Americas, Inc. |
| 1:2019cv07963 |
| December 5, 2019 |
| US District Court for the Northern District of Illinois |
| Manish S Shah |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 13, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 20 MINUTE entry before the Honorable Manish S. Shah: Pursuant to the stipulation of dismissal #19 , this case is dismissed without prejudice and without costs to any party. Civil case terminated. Notices mailed. (psm, ) |
| Filing 19 STIPULATION of Dismissal Without Prejudice (Geisler, Ephraim) |
| Filing 18 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Pfizer, Inc. re notification of affiliates pursuant to local rule 3.2 #13 , answer to complaint #12 (AMENDED) (Rubenstein, Amy) |
| Filing 17 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Merck & Co., Inc. (Maly, Heather) |
| Filing 16 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by AstraZeneca LP, AstraZeneca Pharmaceuticals LP (Maly, Heather) |
| Filing 15 ANSWER to Complaint with Jury Demand by AstraZeneca LP, AstraZeneca Pharmaceuticals LP(Maly, Heather) |
| Filing 14 ANSWER to Complaint with Jury Demand by Merck & Co., Inc.(Maly, Heather) |
| Filing 13 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Pfizer, Inc. re answer to complaint #12 (Rubenstein, Amy) |
| Filing 12 Defendant Pfizer Inc.'s ANSWER to Complaint with Jury Demand and Affirmative Defenses by Pfizer, Inc.(Rubenstein, Amy) |
| Filing 11 ATTORNEY Appearance for Defendant Pfizer, Inc. by Amy Michelle Rubenstein (Rubenstein, Amy) |
| Filing 10 ATTORNEY Appearance for Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals LP, Merck & Co., Inc. by Isaac J. Colunga (Colunga, Isaac) |
| Filing 9 ATTORNEY Appearance for Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals LP, Merck & Co., Inc. by Heather Lynn Maly (Maly, Heather) |
| Filing 8 ANSWER to Complaint with Jury Demand by Takeda Development Center Americas, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.(Hemmings, James) |
| Filing 7 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in this Notice which includes a link to the (MIDP) Standing Order and a Checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the following documents (Notice of Mandatory Initial Discovery and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (lma, ) |
| Filing 6 MAILED Notice of Removal letter to counsel of record. (lma, ) |
| Filing 5 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Development Center Americas, Inc., F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda pharmaceuticals U.S.A., Inc. (Knutson, Sherry) |
| Filing 4 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc., F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda pharmaceuticals U.S.A., Inc. by Sherry Ann Knutson (Knutson, Sherry) |
| Filing 3 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc., F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda pharmaceuticals U.S.A., Inc. by James R M Hemmings (Hemmings, James) |
| Filing 2 CIVIL Cover Sheet (Hemmings, James) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019L012155) filed by Takeda Development Center Americas, Inc., F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda pharmaceuticals U.S.A., Inc. Filing fee $ 400, receipt number 0752-16502771. (Attachments: #1 Exhibit A, #2 Exhibit B)(Hemmings, James) |
| CASE ASSIGNED to the Honorable Manish S. Shah. Designated as Magistrate Judge the Honorable Gabriel A. Fuentes. Case assignment: Random assignment. (kl, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
